NEWTON, Mass.--(BUSINESS WIRE)--Clinical Data, Inc. (NASDAQ: CLDA) today announced consolidated revenues and earnings for the Company’s fiscal third quarter ended December 31, 2006, highlighted by significant revenue growth over the previous quarter and the comparable period last year, as well as continued management of cash burn despite investments in strategic initiatives.
